WaveMan
WaveMan · Company
MCTA · Charming Medical Ltd
> Search tickers & screens ⌘K
LIVE
← All companies

MCTA Charming Medical (MCTA) Insider Trading, Ownership & Congress Trades

Healthcare Services · Services-misc health & allied services, nec · CIK 0002035992
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter

MCTA filings, in plain words

Read the full summary

The latest 5% ownership filing is a 13D by Kit Wong, filed 2026-03-27, for 69.3% of the class. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Charming Medical insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for Charming Medical Ltd in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Foreign private issuer: its insiders are exempt from SEC Form 4 and report in the home market, so their buys and sells do not appear here.

Insider
Filed
Shares
Value
Since filing

no insider purchases or sales on record

0 transactions on record
See all insider buying · insider selling
Showing the latest few. to use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
-27.9% year over year
below 92% of Healthcare Services
Margin
-0.9% net margin
below 52% of Healthcare Services
Buybacks
no share repurchases reported
Short interest
10.5% of the float short (float per yahoo 2026-10-26) · 1000.0 days to cover · settled 2026-09-30
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch MCTA

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

Who owns MCTA: institutional holders (13F)

13F holdings, latest reported quarter
UBS Group AG
24,249 sh
$711.8K
GEODE CAPITAL MANAGEMENT, LLC
10,752 sh
$315.6K
JFS WEALTH ADVISORS, LLC
5,850 sh
$0

Congress trades in MCTA

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

13D: intends to influence · 13G: passive
Kit Wong
Activist 13D · 2026-03-27
69.29%

MCTA planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
NTRACSTLPGNYHIMSWGSPRVATDOCAVAHGHADUSSERABDSX

MCTA financials

Revenue growth
-27.9%
XBRL, annual
Net margin
-0.9%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Free cash flow, TTM
n/a
fewer than four consecutive quarters of operating cash flow
Debt to equity
0.07x
long-term 2026-03-31 plus current 2026-03-31; equity 2026-03-31
Cash flow to debt
n/a
needs four quarters of operating cash flow
Return on equity
n/a
fewer than four consecutive quarters of net income
Return on assets
n/a
fewer than four consecutive quarters of net income
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Enterprise value
n/a
no close on file at or before the as-of date
FCF yield
n/a
no close on file at or before the as-of date
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2026-032025-032024-03
Revenue$4.8M$6.2M$6.0M
Operating income-$29.2K$1.4M$1.0M
Net income-$22.6K$1.2M$777.8K
EPS (diluted)0.000.080.05
Operating cash flow-$1.2M$425.9K$295.4K
Cash$4.7M$816.8Kn/a
Long-term debt$185.8Kn/an/a
SEC XBRL, fiscal years, as known on 2026-10-28

MCTA Stock Sonar score 3/7 axes

Find similar shapesCompare

MCTA ranks highest on financial health (75th percentile) and risk and compliance (23rd), and lowest on growth (8th), among Healthcare Services peers.

Financial health
75
Inputs
  • Debt to equity0.07x · 75 pct, sector of 61
  • Cash flow to debtneeds four quarters of operating cash flow
Growth
8
Inputs
  • Revenue growth, YoY-27.9% · 8 pct, sector of 87
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Risk and compliance
23
Inputs
  • Short interest, % of float+10.5% · 23 pct, sector of 95
  • Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
  • EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
  • New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Profitability, Insider conviction, Institutional and government, US patents
  • Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies